Market Tracker

02/17 5:16pm ET

Lannett Company Inc (NYSE:LCI)

22.40
Delayed Data
As of Feb 17
 -0.60 / -2.61%
Today’s Change
16.75
Today|||52-Week Range
39.99
+1.59%
Year-to-Date
Will Lannett (LCI) Continue to Surge Higher?
Feb 16 / Zacks.com - Paid Partner Content
AcelRx Pharmaceuticals (ACRX) in Focus: Stock Rises 5.3%
Feb 06 / Zacks.com - Paid Partner Content
Weekly CEO Buys Highlights
Feb 13 / GuruFocus News - Paid Partner Content
GNC Holdings (GNC) Q4 Earnings: A Surprise in the Cards?
Feb 06 / Zacks.com - Paid Partner Content
Express Scripts (ESRX) Q4 Earnings: What's in the Cards?
Feb 08 / Zacks.com - Paid Partner Content
Affimed (AFMD) Shows Strength: Stock Moves 8.1% Higher
Feb 06 / Zacks.com - Paid Partner Content
Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?
Feb 07 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close23.00
Today’s open22.85
Day’s range22.25 - 23.20
Volume561,035
Average volume (3 months)1,181,333
Market cap$833.0M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-70.30%
Earnings growth (this year)+0.62%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+39.14%
P/E ratioNM
Price/Sales1.57
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.40+2.22%
INSYINSYS Therapeutics I...+0.36+3.35%
ADROAduro Biotech Inc+0.35+3.06%
CLLSCellectis SA-0.10-0.44%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.86
Annual revenue (last year)$566.1M
Annual profit (last year)$44.8M
Net profit margin7.91%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
CFO, Treasurer &
Vice President-Finance
Martin P. Galvan
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts